Clinical Trials Browser

Neoplasm Metastasis × Chemoradiotherapy × Head & Neck × Clear all

NCT05520814 2023-09-21

PD-1 Inhibitors Plus Chemoradiotherapy for Metastatic Nasopharyngeal Carcinoma: an Open-label Single-arm, Phase II Trial

Phase 2 Unknown

Nasopharyngeal Carcinoma, Neoplasm Metastasis